Increased nuclear TXNRD1 levels were found in high-grade, versus low-grade, human prostate cancers [53], and correlated with prostate cancer progression and androgen-deprived castration-resistant prostate cancer (CRPC) cells, suggesting that CRPC possesses an enhanced dependency on TXNRD1 [54]. The gene discussed is TXNRD1; the disease is prostate carcinoma.